Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Chugai Pharmaceutical Co., Ltd
  6. News
  7. Summary
    4519   JP3519400000

CHUGAI PHARMACEUTICAL CO., LTD

(4519)
  Report
Delayed Japan Exchange  -  07:03 2022-12-05 pm EST
3608.00 JPY   -0.06%
11/25Chugai Pharmaceutical Co., Ltd. - Transfer and Future Marketing of Osteoporosis Agent Bonviva in Japan
AQ
11/24Taisho Pharmaceutical Holdings Co., Ltd. (TSE:4581) entered into an agreement to acquire Bonviva Business from Chugai Pharmaceutical Co., Ltd. and F. Hoffmann-La Roche.
CI
11/21Chugai Pharmaceutical Co., Ltd. - Organizational and Personnel Changes
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Chugai Pharmaceutical Co., Ltd. - Relief Efforts Support for Season's Fifteenth Typhoon

10/05/2022 | 08:27am EST

TOKYO - Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that it decided a financial donation to support the relief efforts and reconstruction in the disaster area where extensive damage occurred due to the season's fifteenth typhoon.

We sincerely hope for the early reconstruction of the disaster area.

Contact:

Tomoko Shimizu

Tel: +81-3-3273-0881

Email: pr@chugai-pharm.co.jp

(C) 2022 Electronic News Publishing, source ENP Newswire

Stocks mentioned in the article
ChangeLast1st jan.
CHUGAI PHARMACEUTICAL CO., LTD -0.11% 3608 Delayed Quote.-4.42%
ROCHE HOLDING AG 0.42% 309.55 Delayed Quote.-18.69%
All news about CHUGAI PHARMACEUTICAL CO., LTD
11/25Chugai Pharmaceutical Co., Ltd. - Transfer and Future Marketing of Osteoporosis Agent B..
AQ
11/24Taisho Pharmaceutical Holdings Co., Ltd. (TSE:4581)..
CI
11/21Chugai Pharmaceutical Co., Ltd. - Organizational and Personnel Changes
AQ
11/20Chugai Pharmaceutical : Organizational and Personnel Changes
PU
11/14Chugai Pharmaceutical Co., Ltd. - Contribution of Para-transit Vehicles to Welfare Serv..
AQ
11/07Chugai Pharmaceutical and IBM Japan Initiate Operation of Digital Infrastructure at Uki..
AQ
10/31Chugai Pharmaceutical Co., Ltd. - Purchase of Land for Business in Ukima
AQ
10/28Chugai Pharmaceutical : Purchase of Land for Business in Ukima
PU
10/25Chugai Announces 2022 3rd Quarter Results
AQ
10/25Chugai Pharmaceutical's FY22 Nine-month Net Income Surges 33% on Significant Jump in Sa..
MT
More news
Financials
Sales 2022 1 196 B 8 766 M 8 766 M
Net income 2022 356 B 2 607 M 2 607 M
Net cash 2022 531 B 3 895 M 3 895 M
P/E ratio 2022 16,7x
Yield 2022 2,20%
Capitalization 5 938 B 43 529 M 43 529 M
EV / Sales 2022 4,52x
EV / Sales 2023 5,02x
Nbr of Employees 7 664
Free-Float 38,0%
Chart CHUGAI PHARMACEUTICAL CO., LTD
Duration : Period :
Chugai Pharmaceutical Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHUGAI PHARMACEUTICAL CO., LTD
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 3 610,00 JPY
Average target price 4 416,15 JPY
Spread / Average Target 22,3%
EPS Revisions
Managers and Directors
Tatsuro Kosaka Manager-Pharmaceutical Business Strategy Office
Osamu Okuda Manager-Life Cycle Management II
Itagaki Toshiaki CFO, Manager-Information Technology & Accounting
Hisafumi Okabe Senior Executive Officer & Head-Research
Junichi Nezu Executive Officer, GM-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
CHUGAI PHARMACEUTICAL CO., LTD-4.42%43 395
JOHNSON & JOHNSON4.57%467 679
ELI LILLY AND COMPANY35.67%356 089
ABBVIE INC.20.87%289 331
NOVO NORDISK A/S22.04%285 887
PFIZER, INC.-13.78%285 774